Jing Zhou
Bengbu Medical College(CN)Sichuan University(CN)West China Hospital of Sichuan University(CN)China General Nuclear Power Corporation (China)(CN)ShenZhen People’s Hospital(CN)First Affiliated Hospital of Bengbu Medical College(CN)Sichuan University of Science and Engineering(CN)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Thyroid Cancer Diagnosis and Treatment, Microtubule and mitosis dynamics, Monoclonal and Polyclonal Antibodies Research, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development(2014)291 cited
- → A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission(2015)249 cited
- → Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction(2012)167 cited
- → Spectroscopic Studies of Substrate Interactions with Clavaminate Synthase 2, a Multifunctional α-KG-Dependent Non-Heme Iron Enzyme: Correlation with Mechanisms and Reactivities(2001)150 cited
- → Circular Dichroism and Magnetic Circular Dichroism Spectroscopic Studies of the Non-Heme Ferrous Active Site in Clavaminate Synthase and Its Interaction with α-Ketoglutarate Cosubstrate(1998)148 cited
- → The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents(2015)